Trial Search Results
Pediatric PET/MR Image Registry
The purpose of this study is to compare whole body magnetic resonance (MR) imaging, whole body positron emission tomography (PET)/MR imaging, and (if available) PET/Computed Tomography (CT) imaging for the diagnosis of tumors in children and young adults. Sensitivities, specificities and diagnostic accuracies of the different imaging modalities will be compared for significant differences.
Stanford is currently accepting patients for this trial.
- Diagnostic Test: PET/MR imaging
- Diagnostic Test: MR imaging
- Diagnostic Test: PET/CT imaging
- Patients with proven solid tumors or newly diagnosed mass strongly suspected to
represent a solid tumor.
- We might also include some patients with leukemia if there is concern for a focal
lesion in any of their organs.
- Participant's parents (if participant is under 18) or the participant (if participant
is 18 years or older) must willingly give written informed consent prior to any image
transfer to the image registry.
- Patient has contraindications for MRI or PET/MR. This includes patients with cardiac
pacemakers or intracranial vascular clips as well as patients with a blood glucose
level > 200 mg/dl.
- Lack of parental permission (if participant is younger than 18) or lack of informed
consent (if participant is at least 18 years of age).
- Patient has a CNS primary tumor.
- Pregnant women and fetuses
Ages Eligible for Study
N/A - 40 Years
Genders Eligible for Study